Recommendations of follow-up after treatment of germ cell tumors Journal Article

  


Authors: Kondagunta, G. V.; Sheinfeld, J.; Motzer, R. J.
Article Title: Recommendations of follow-up after treatment of germ cell tumors
Abstract: Patients diagnosed with germ cell tumors (GCT) are relatively young, and most are rendered disease-free by primary treatment. Also, second-line therapies in nearly all instances are potentially curative. Therefore, the schedule and modalities of follow-up testing are important issues in detecting recurrence of GCT and for detecting secondary malignancies and complications of therapy. Follow-up is usually based on the pattern and probability of recurrence following primary therapy according to stage and histology. The National Comprehensive Cancer Network has outlined guidelines (http://www.nccn.org/physician_gls/index.html). There is a paucity of randomized data regarding the follow-up regimens most effective in identifying relapsed disease. Optimal means of imaging and frequency of physician visits and serum marker level measurements need to be further addressed. © 2003 Elsevier Inc. All rights reserved.
Keywords: treatment outcome; cancer surgery; clinical trial; histopathology; review; cancer recurrence; cisplatin; cancer combination chemotherapy; cancer adjuvant therapy; cancer radiotherapy; cancer staging; drug megadose; follow up; antineoplastic agent; neoplasm staging; metastasis; computer assisted tomography; neoplasm recurrence, local; etoposide; mass screening; practice guideline; tumor marker; ifosfamide; vinblastine; bleomycin; neoplasms, second primary; germ cell tumor; seminoma; continuity of patient care; non seminomatous germinoma; germinoma; practice guidelines; humans; prognosis; human; priority journal
Journal Title: Seminars in Oncology
Volume: 30
Issue: 3
ISSN: 0093-7754
Publisher: Elsevier Inc.  
Date Published: 2003-06-01
Start Page: 382
End Page: 389
Language: English
DOI: 10.1016/s0093-7754(03)00098-8
PUBMED: 12870140
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-0038806779&partnerID=40&md5=fc9dca1805128c52fd335bab95fa8a39
Notes: Export Date: 25 September 2014 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Gnanamba Kondagunta
    46 Kondagunta
  2. Robert Motzer
    1243 Motzer
  3. Joel Sheinfeld
    254 Sheinfeld
Related MSK Work